Melioidosis: A clinical overview

British Medical Bulletin

Volumn 99, Issue 1, 2011, Pages 125-139

  Limmathurotsakul, Direk ^a   Peacock, Sharon J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Burkholderia; Melioidosis; Pseudomallei; Review

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; GRANULOCYTE COLONY STIMULATING FACTOR; MEROPENEM;

ANTIMICROBIAL THERAPY; AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; COMBINATION CHEMOTHERAPY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; MELIOIDOSIS; MONOTHERAPY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT INFECTION; REVIEW; SEPSIS; SEPTIC SHOCK; SEROCONVERSION; SOUTHEAST ASIA; TREATMENT DURATION;

ANTI-INFECTIVE AGENTS; ASIA, SOUTHEASTERN; AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; CARBAPENEMS; CEFTAZIDIME; COMMUNICABLE DISEASE CONTROL; DISEASE RESERVOIRS; HUMANS; MELIOIDOSIS; RECURRENCE; RISK ASSESSMENT; SEPSIS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; WORLD HEALTH;

EID: 80052750008     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr007     Document Type: Review

References (51)

1. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 2008;102(Suppl. 1):S1-4.
2. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005;18:383-416. (Pubitemid 40548298)
3. Suputtamongkol Y, Hall AJ, Dance DA et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol 1994;23:1082-90. (Pubitemid 24331225)
4. Currie BJ, Fisher DA, Howard DM et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 2000;74:121-7. (Pubitemid 30069782)
5. Merianos A, Patel M, Lane JM et al. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health 1993;24:425-35.
6. Howe C, Sampath A, Spotnitz M. The pseudomallei group: a review. J Infect Dis 1971;124:598-606.
7. Limmathurotsakul D, Chaowagul W, Day NP et al. Patterns of organ involvement in recurrent melioidosis. Am J Trop Med Hyg 2009;81:335-7.
8. Inglis TJ, Garrow SC, Henderson M et al. Burkholderia pseudomallei traced to water treatment plant in Australia. Emerg Infect Dis 2000;6:56-9. (Pubitemid 30126454)
9. Currie BJ, Mayo M, Anstey NM et al. A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg 2001;65:177-9. (Pubitemid 32847806)
10. Chantratita N, Wuthiekanun V, Limmathurotsakul D et al. Genetic diversity and microevolution of Burkholderia pseudomallei in the environment. PLoS Negl Trop Dis 2008;2:e182.
11. Inglis TJ, Foster NF, Gal D et al. Preliminary report on the northern Australian melioidosis environmental surveillance project. Epidemiol Infect 2004;132:813-20. (Pubitemid 39307337)
12. White NJ. Melioidosis. Lancet 2003;361:1715-22. (Pubitemid 36577448)
13. McCormick JB, Sexton DJ, McMurray JG et al. Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med 1975;83:512-3.
14. Holland DJ, Wesley A, Drinkovic D et al. Cystic fibrosis and Burkholderia pseudomallei Infection: an emerging problem? Clin Infect Dis 2002;35:e138-40.
15. Kunakorn M, Jayanetra P, Tanphaichitra D. Man-to-man transmission of melioidosis. Lancet 1991;337:1290-1.
16. Ashdown LR. Nosocomial infection due to Pseudomonas pseudomallei: two cases and an epidemiologic study. Rev Infect Dis 1979;1:891-4.
17. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 2010;82:1113-7.
18. How SH, Ng TH, Jamalludin AR et al. Pahang melioidosis registry. Med J Malaysia 2009;64:27-30.
19. Heng BH, Goh KT, Yap EH et al. Epidemiological surveillance of melioidosis in Singapore. Ann Acad Med Singapore 1998;27:478-84. (Pubitemid 28457716)
20. Currie BJ, Jacups SP, Cheng AC et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health 2004;9:1167-74. (Pubitemid 39573988)
21. Faa AG, Holt PJ. Melioidosis in the Torres Strait islands of far North Queensland. Commun Dis Intell 2002;26:279-83.
22. Warner JM, Pelowa DB, Currie BJ et al. Melioidosis in a rural community of Western Province, Papua New Guinea. Trans R Soc Trop Med Hyg 2007;101:809-13. (Pubitemid 46930623)
23. Chen YS, Lin HH, Mu JJ et al. Distribution of melioidosis cases and viable Burkholderia pseudomallei in soil: evidence for emerging melioidosis in Taiwan. J Clin Microbiol 2010;48:1432-4.
24. Chierakul W, Winothai W, Wattanawaitunechai C et al. Melioidosis in 6 tsunami survivors in southern Thailand. Clin Infect Dis 2005;41:982-90. (Pubitemid 41368220)
25. Su HP, Yang HW, Chen YL. et al. Prevalence of melioidosis in the Er-Ren River Basin, Taiwan: implications for transmission. J Clin Microbiol 2007;45:2599-603.
26. Chierakul W, Rajanuwong A, Wuthiekanun V et al. The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans R Soc Trop Med Hyg 2004;98:678-86. (Pubitemid 40029120)
27. Wuthiekanun V, Chierakul W, Langa S et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg 2006;74:1074-5. (Pubitemid 351627418)
28. Ngauy V, Lemeshev Y, Sadkowski L et al. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005;43:970-2. (Pubitemid 40256075)
29. Currie BJ, Fisher DA, Anstey NM et al. Melioidosis acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 2000;94:301-4. (Pubitemid 30406565)
30. Limmathurotsakul D, Jamsen K, Arayawichanont A et al. Defining the true sensitivity of culture for the diagnosis of melioidosis using bayesian latent class models. PLoS One 2010;5.
31. Kanaphun P, Thirawattanasuk N, Suputtamongkol Y et al. Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J Infect Dis 1993;167:230-3. (Pubitemid 23002866)
32. Gibney KB, Cheng AC, Currie BJ. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis 2008;47:603-9.
33. Peacock SJ, Chieng G, Cheng AC et al. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 2005;43:5359-61. (Pubitemid 41484060)
34. Wuthiekanun V, Cheng AC, Chierakul W et al. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother 2005;55:1029-31. (Pubitemid 40883194)
35. Chantratita N, Wuthiekanun V, Limmathurotsakul D et al. Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am J Trop Med Hyg 2007;77:814-7. (Pubitemid 351837820)
36. Meumann EM, Novak RT, Gal D et al. Clinical evaluation of a type III secretion system realtime PCR assay for diagnosing melioidosis. J Clin Microbiol 2006;44:3028-30. (Pubitemid 44228612)
37. Chaowagul W, Simpson AJ, Suputtamongkol Y et al. Empirical cephalosporin treatment of melioidosis. Clin Infect Dis 1999;28:1328. (Pubitemid 29272818)
38. Stephens DP, Fisher DA, Currie BJ. An audit of the use of granulocyte colony-stimulating factor in septic shock. Intern Med J 2002;32:143-8. (Pubitemid 36124669)
39. Cheng AC, Limmathurotsakul D, Chierakul W et al. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis 2007;45:308-14. (Pubitemid 47101026)
40. Chierakul W, Anunnatsiri S, Short JM et al. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis 2005;41:1105-13. (Pubitemid 41429472)
41. Morse LP, Moller CC, Harvey E et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol 2009;182:542-7; discussion 47.
42. Limmathurotsakul D, Chaowagul W, Chierakul W et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006;43:979-86. (Pubitemid 44631096)
43. Chierakul W, Wangboonskul J, Singtoroj T et al. Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis. J Antimicrob Chemother 2006;58:1215-20. (Pubitemid 44884141)
44. Cheng AC, Chierakul W, Chaowagul W et al. Consensus guidelines for dosing of amoxicillinclavulanate in melioidosis. Am J Trop Med Hyg 2008;78:208-9. (Pubitemid 351844549)
45. Chaowagul W, Chierakul W, Simpson AJ et al. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob Agents Chemother 2005;49:4020-5. (Pubitemid 41400941)
46. Limmathurotsakul D, Chaowagul W, Wongsrikaew P et al. Variable presentation of neurological melioidosis in Northeast Thailand. Am J Trop Med Hyg 2007;77:118-20. (Pubitemid 351844362)
47. Cheng AC, Obrien M, Jacups SP et al. C-reactive protein in the diagnosis of melioidosis. Am J Trop Med Hyg 2004;70:580-2. (Pubitemid 38658158)
48. Cheng AC, Jacups SP, Ward L et al. Melioidosis and Aboriginal seasons in northern Australia. Trans R Soc Trop Med Hyg 2008;102(Suppl. 1):S26-9.
49. Walsh AL, Smith MD, Wuthiekanun V et al. Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 1995;21:1498-500. (Pubitemid 26066650)
50. Maharjan B, Chantratita N, Vesaratchavest M et al. Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol 2005;43:6032-4. (Pubitemid 43100656)
51. Limmathurotsakul D, Chaowagul W, Chantratita N et al. A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis. PLoS Negl Trop Dis 2008;2:e327.